Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Jun. 30, 2025	Dec. 31, 2024
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $151 and $160, respectively); and amortized cost: $321,735 and $307,421, respectively	$ 298,737	$ 281,043
Equity securities	790	712
Contractholder-directed equity securities and fair value option securities, at estimated fair value	11,694	10,672
Mortgage loans (net of allowance for credit loss of $1,196 and $800, respectively)	86,868	89,012
Policy loans	8,664	8,545
Real estate and real estate joint ventures (includes $389 and $378, respectively, under the fair value option; $152 and $65, respectively, of real estate held-for-sale; $210 and $183, respectively, relating to variable interest entities)	14,007	13,342
Other limited partnership interests	14,279	14,378
Short-term investments, principally at estimated fair value	5,300	5,156
Other invested assets (includes $1,825 and $1,851, respectively, of leveraged and direct financing leases; $523 and $424, respectively, relating to variable interest entities)	16,352	18,504
Total investments	456,691	441,364
Cash and cash equivalents, principally at estimated fair value	22,178	20,068
Accrued investment income	3,532	3,489
Premiums, reinsurance and other receivables (includes $0 and $47, respectively, relating to variable interest entities)	31,503	29,761
Market risk benefits, at estimated fair value	352	372
Deferred policy acquisition costs and value of business acquired	20,993	19,627
Current income tax recoverable	554	295
Deferred income tax asset	2,925	2,994
Goodwill	9,142	8,901
Other assets	11,425	11,082
Separate account assets	143,175	139,504
Total assets	702,470	677,457
Liabilities
Future policy benefits	198,965	193,646
Policyholder account balances	232,433	221,445
Market risk benefits, at estimated fair value	2,709	2,581
Other policy-related balances	19,899	18,899
Policyholder dividends payable	367	385
Payables for collateral under securities loaned and other transactions	17,147	17,128
Short-term debt (includes $106 and $133, respectively, relating to variable interest entities)	379	465
Long-term debt	15,374	15,086
Collateral financing arrangement	438	476
Subordinated debt securities	4,153	3,164
Deferred income tax liability	430	132
Other liabilities (includes $41 and $0, respectively, relating to variable interest entities)	39,074	36,843
Separate account liabilities	143,175	139,504
Total liabilities	674,543	649,754
Contingencies, Commitments and Guarantees (Note 20)
MetLife, Inc.’s stockholders’ equity:
Preferred stock, par value $0.01 per share; $3,905 aggregate liquidation preference	0	0
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,195,301,071 and 1,194,168,628 shares issued, respectively; 666,827,962 and 689,211,065 shares outstanding, respectively	12	12
Additional paid-in capital	33,822	33,791
Retained earnings	43,447	42,626
Treasury stock, at cost; 528,473,109 and 504,957,563 shares, respectively	(29,737)	(27,798)
Accumulated other comprehensive income (loss)	(19,859)	(21,186)
Total MetLife, Inc.’s stockholders’ equity	27,685	27,445
Noncontrolling interests	242	258
Total equity	27,927	27,703
Total liabilities and equity	$ 702,470	$ 677,457